Skip to main content
大唐药业 logo

大唐药业 — Investor Relations & Filings

Ticker · 920433 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 420 across all filing types
Latest filing 2022-12-05 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920433

About 大唐药业

http://www.nmdt.com.cn/

Inner Mongolia Datang Pharmaceutical specializes in the research, development, and production of traditional Chinese and Mongolian medicines. The company focuses on modernizing ethnic medicinal formulas through advanced biotechnology and standardized manufacturing processes. Its product portfolio covers therapeutic areas including respiratory health, cardiovascular conditions, and gastrointestinal disorders. Notable offerings include Xuanfei Zhike granules and specialized Mongolian medicinal preparations. The organization integrates traditional knowledge with contemporary clinical research to develop proprietary formulations. By maintaining rigorous quality management systems and investing in automated production lines, the company aims to enhance the efficacy and accessibility of ethnic medicines for a broad patient base.

Recent filings

Filing Released Lang Actions
内蒙古上都律师事务所关于内蒙古大唐药业股份有限公司2022年第五次临时股东大会法律意见书
Regulatory Filings
2022-12-05 Chinese
2022 年第五次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement for the 2022 fifth extraordinary general meeting of shareholders of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on shareholder meeting decisions, voting outcomes, and related procedural compliance. There is no indication of financial statements, audit reports, or earnings data. The document is a formal announcement of shareholder meeting resolutions and voting results, fitting the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 2801 characters, consistent with a detailed voting results announcement rather than a full report or presentation.
2022-12-05 Chinese
独立董事关于第三届董事会第九次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on a board meeting resolution regarding the change of use of some raised funds. It references the board meeting, company law, stock exchange listing rules, and internal company regulations. The document is short (671 characters) and is an announcement of the independent directors' opinion rather than a full report or financial statement. It relates to board/management information about a board meeting decision and does not contain financial data or detailed report content. Therefore, it fits best under Board/Management Information (MANG).
2022-11-17 Chinese
第三届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the ninth meeting of the third board of directors of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the meeting's attendance, the agenda items discussed, voting results, and references to further announcements on the official exchange platform. The content focuses on board meeting decisions, including investment increases, changes in fund usage, credit applications, and convening a shareholders' meeting. There is no detailed financial data, earnings information, or full report content. The document is clearly a Board/Management Information announcement about board meeting resolutions and decisions, not a full report or financial statement.
2022-11-17 Chinese
中泰证券股份有限公司关于内蒙古大唐药业股份有限公司变更部分募集资金用途的核查意见
Regulatory Filings
2022-11-17 Chinese
关于召开2022 年第五次临时股东大会通知公告（提供网络投票）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the 2022 fifth extraordinary general meeting of shareholders (临时股东大会) for Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items to be discussed, and procedural information for shareholders. There is no financial data or report content included, only the announcement of the meeting and its agenda. The document length is about 2804 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document is best classified as a Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2022-11-17 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.